Edmonton – September 18, 2026 -- Aurora Cannabis Inc. (TSX: ACB) (NASDAQ: ACB) reaffirmed its fiscal 2027 second-quarter guidance for sequential growth in net revenue and adjusted EBITDA, citing new EU-GMP capacity and expanding market share in Germany, Poland and the United Kingdom.